Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2021) 73 EP211 | DOI: 10.1530/endoabs.73.EP211

University Hospital Hedi Chaker, Endocrinology, Sfax, Tunisia


Introduction

Cardiothyreosis is associated with higher morbidity and mortality than other forms of hyperthyroidism. The aim of our study was to identify its therapeutic and evolutive aspects in an adult population of southern Tunisia.

Methods

Retrospective study including all cases of cardiothyreosis followed in our department during a period of 20 years.

Results

100 cases of cardiothyreosis were collected. To treat the hyperthyroidism, the association of antithyroid drugs and radioactive iodine was used in 52%of patients. Thyroidectomy was performed in 9%of cases. For the cardiothyreosis, 90%of patients went under ß-blockers. All patients with congestive heart failure (CHF) were treated with diuretics. Patients with atrial fibrillation have received anticoagulants. The most used molecule was acenocoumarol (86%). The evolution of cardiothyreosis was favorable in 64.4%of cases while 9%of patients died. In our study, the association of atrial fibrillation and CHF in the same patient, and the elevation of the end-systolic and end-diastolic diameters of the left ventricular were significantly associated with higher risk of mortality (P < 0.05).

Conclusion

While its diagnosis is often easy, the management of cardiothyreosis remains difficult. The prognosis of this disease may be ameliorated by an early and efficient treatment.

Volume 73

European Congress of Endocrinology 2021

Online
22 May 2021 - 26 May 2021

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.